Is Dual mTORC1 and mTORC2 Therapeutic Blockade Clinically Feasible in Cancer?
JAMA Oncol
.
2019 Nov 1;5(11):1564-1565.
doi: 10.1001/jamaoncol.2019.2525.
Authors
Nisha Unni
1
,
Carlos L Arteaga
1
2
Affiliations
1
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
2
Harold C. Simmons Comprehensive Cancer Center, Dallas, Texas.
PMID:
31465107
DOI:
10.1001/jamaoncol.2019.2525
No abstract available